ROPHIBIO Competitors and Similar CompaniesClear all

ROPHIBIO's competitors and similar companies include Amgen, Exicure and Zyngenia.
ROPHIBIO
ROPHIBIO
ROPHIBIO is a company developing protein/antibody, gene/cell, and stem cell therapeutics.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
Exicure
Exicure
Exicure is a biotechnology company developing immunomodulatory and gene regulating drugs against validated targets.
Zyngenia
Zyngenia
Zyngenia is a company developing biotherapeutics that simultaneously target multiple physiologic pathways.
Founding Date
Founding Date
2007
Founding Date
1980
Founding Date
2011
Founding Date
2009
Type
Type
Private
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Cheongwon-gun, KR HQ
Gaithersburg, US
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Sydney, AU
Wien, AT
Diegem, BE
Santo Amaro, BR
see more
Locations
Skokie, US HQ
Chicago, US
Locations
Washington, US HQ
Employees
Employees
N/A
Employees
25,200
Employees
29
Employees
N/A
Valuation ($)
Valuation ($)
N/A
Valuation ($)
170.4 b
Valuation ($)
5.6 m
Valuation ($)
N/A

Financial

Net income
Net income
N/A
Net income
$7.7b (FY, 2025)
Net income
($4.9m) (FY, 2025)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 94m
Total funding raised
$ 25m
For sources of this data, please see the company profile

View Company Profiles

Amgen
HQ
Thousand Oaks, US
Employees
25,200

Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.

View company
Exicure
HQ
Skokie, US
Employees
29

Exicure is a biotechnology company developing immunomodulatory and gene regulating drugs against validated targets.

View company
Zyngenia
HQ
Washington, US

Zyngenia is a company developing biotherapeutics that simultaneously target multiple physiologic pathways.

View company